Literature DB >> 11984101

The Chinese translation of the Index of Nausea, Vomiting, and Retching.

Mei R Fu1, Verna Rhodes, Bo Xu.   

Abstract

The purpose of this study was to determine reliability and validity of the Chinese version of the Index of Nausea, Vomiting, and Retching (INVR) and the Index of Nausea and Vomiting Form 2 (INV-2) to provide a reliable and valid measure of nausea, vomiting, and retching for Chinese nurses and other healthcare providers. An integrative translation method was used in the study. The reliability and validity of the Chinese versions of the INVR and the INV-2 was evaluated using test-retest, parallel forms, and crossover design. A convenience sample of 177 Chinese-speaking participants was accrued from a large teaching cancer institute and a teaching obstetric hospital in Beijing, Peoples Republic of China. The integrative translation method was proven to be an effective method for translating instruments from the source to the target language. The Chinese versions of both the INV-2 and INVR were found to have high Cronbach's alpha scores and high agreement rates. The responses to the Chinese version of INVR were more frequently consistent than the responses to the INV-2. The majority of the patients voiced preference for the INVR. The findings suggest the significance of the Chinese versions of INVR and INV-2 in terms of nursing practice. The findings also support the cross-cultural method for future study at international level.

Entities:  

Mesh:

Year:  2002        PMID: 11984101     DOI: 10.1097/00002820-200204000-00010

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  8 in total

Review 1.  A review of patient self-report tools for chemotherapy-induced nausea and vomiting.

Authors:  Sarah G Brearley; Caroline V Clements; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2008-06-13       Impact factor: 3.603

Review 2.  The psychometric properties of cancer multisymptom assessment instruments: a clinical review.

Authors:  Aynur Aktas; Declan Walsh; Jordanka Kirkova
Journal:  Support Care Cancer       Date:  2015-04-19       Impact factor: 3.603

3.  Psychometric assessment of the Chinese version of the MASCC Antiemesis Tool (MAT) for measuring chemotherapy-induced nausea and vomiting.

Authors:  Jing-Yu Tan; Lorna K P Suen; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2016-04-02       Impact factor: 3.603

4.  Acupressure and ginger to relieve nausea and vomiting in pregnancy: a randomized study.

Authors:  Farzaneh Saberi; Zohreh Sadat; Masoumeh Abedzadeh-Kalahroudi; Mahboobeh Taebi
Journal:  Iran Red Crescent Med J       Date:  2013-09-05       Impact factor: 0.611

5.  Effect of ginger on relieving nausea and vomiting in pregnancy: a randomized, placebo-controlled trial.

Authors:  Farzaneh Saberi; Zohreh Sadat; Masoumeh Abedzadeh-Kalahroudi; Mahboobeh Taebi
Journal:  Nurs Midwifery Stud       Date:  2014-04-17

6.  Guided Imagery And Progressive Muscle Relaxation as a Cluster of Symptoms Management Intervention in Patients Receiving Chemotherapy: A Randomized Control Trial.

Authors:  Andreas Charalambous; Margarita Giannakopoulou; Evaggelos Bozas; Yiola Marcou; Petros Kitsios; Lefkios Paikousis
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240

7.  Efficacy differences of electroacupuncture with single acupoint or matching acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial.

Authors:  Bo Chen; Yang Guo; Xue Zhao; Li-Li Gao; Bo Li; Tian-Yi Zhao; Qi-Wen Zhang; Jin-Xing Zou; Ming-Yue Li; Yong-Ming Guo; Yi Guo; Xing-Fan Pan
Journal:  Trials       Date:  2017-10-13       Impact factor: 2.279

8.  Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial.

Authors:  Jing-Yu Tan; Alex Molassiotis; Lorna K P Suen; Jian Liu; Tao Wang; Hui-Rong Huang
Journal:  BMC Complement Med Ther       Date:  2022-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.